Delta-Fly Pharma Inc
TSE:4598
Cash Flow Statement
Cash Flow Statement
Delta-Fly Pharma Inc
Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||
Net Income |
(1 552)
|
(1 286)
|
(859)
|
(952)
|
(964)
|
(1 029)
|
(1 326)
|
(1 304)
|
|
Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Other Non-Cash Items |
2
|
2
|
7
|
8
|
1
|
(1)
|
8
|
9
|
|
Cash Taxes Paid |
3
|
3
|
9
|
3
|
(2)
|
3
|
3
|
3
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(101)
|
12
|
123
|
40
|
21
|
19
|
13
|
(28)
|
|
Cash from Operating Activities |
(1 649)
N/A
|
(1 270)
+23%
|
(727)
+43%
|
(902)
-24%
|
(940)
-4%
|
(1 009)
-7%
|
(1 303)
-29%
|
(1 322)
-1%
|
|
Investing Cash Flow | |||||||||
Capital Expenditures |
(13)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
|
Cash from Investing Activities |
(13)
N/A
|
(1)
+95%
|
(1)
+30%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-2%
|
1
N/A
|
|
Financing Cash Flow | |||||||||
Net Issuance of Common Stock |
107
|
0
|
875
|
995
|
120
|
(0)
|
879
|
1 090
|
|
Net Issuance of Debt |
(7)
|
(7)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
|
Other |
0
|
0
|
6
|
0
|
0
|
0
|
4
|
0
|
|
Cash from Financing Activities |
100
N/A
|
(7)
N/A
|
875
N/A
|
999
+14%
|
120
-88%
|
(0)
N/A
|
883
N/A
|
1 094
+24%
|
|
Change in Cash | |||||||||
Effect of Foreign Exchange Rates |
(2)
|
(2)
|
(3)
|
(2)
|
0
|
1
|
(3)
|
(4)
|
|
Net Change in Cash |
(1 565)
N/A
|
(1 280)
+18%
|
145
N/A
|
94
-35%
|
(820)
N/A
|
(1 008)
-23%
|
(424)
+58%
|
(231)
+46%
|
|
Free Cash Flow | |||||||||
Free Cash Flow |
(1 663)
N/A
|
(1 271)
+24%
|
(727)
+43%
|
(902)
-24%
|
(940)
-4%
|
(1 010)
-7%
|
(1 303)
-29%
|
(1 322)
-1%
|